Abstract
Objectives: Data from the California Cancer Registry were used to model the effect of race/ethnicity, census-derived socioeconomic status (SES), age, year, and stage at diagnosis on prostatectomy utilization in men diagnosed with prostate cancer from 1990 through 1993. Treatment received was compared with the National Cancer Institute's Physician Data Query (PDQ) to evaluate concordance.
Methods: Odds ratios (OR) and 95% confidence intervals (CI) were estimated to assess the likelihood of (a) receiving a prostatectomy and (b) receiving a treatment in concordance with the PDQ. Non-concordance was defined as a prostatectomy performed on a patient who was either diagnosed with AJCC stage III or IV prostate cancer, or was older than 70 years. All other treatments were considered compliant with the PDQ.
Results: Regardless of the stage at diagnosis, men who were younger and lived in a neighborhood with higher income and education levels were the most likely to receive a prostatectomy as opposed to other treatments. Black men were the least likely to be treated with prostatectomy (OR = 0.6, CI = 0.5–0.6), and the differential was evident within all income levels examined. With respect to the PDQ, black men were 1.4 times more likely to receive concordant treatment than white men (OR = 1.4, CI = 1.3–1.5).
Conclusions: California black men are receiving less aggressive treatment (that is more concordant with the PDQ) when diagnosed with prostate cancer.
Similar content being viewed by others
References
National Cancer Institute (1993) Physician Data Query. Prostate Cancer Treatment. Bethesda, MD: National Institutes of Health.
Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer (1992) Manual for Staging of Cancer. Philadelphia, PA: J.B. Lippincott.
Perez CA, Michalski J, Lockett MA (1995) Radiation therapy in the treatment of localized prostate cancer: an alternative to an emerging consensus. Missouri Med 92: 696-704.
Gibbons RP (1995) Management of stage 1c prostate cancer. Cancer (Suppl.) 75: 1900-1902.
Zinke H, Bergstrath EJ, Blute ML, et al. (1994) Radical prostatectomy for clinically localized prostate cancer: long term results of 1143 patients from a single institution. J Clin Oncol 12: 2254-2263.
Chodak GW, Thisted RA, Gerber GS, et al. (1994) Results of conservative management of clinically localized prostate cancer. N Engl J Med 330: 242-248.
Graversen PH, Nielsen KT, Gasser TC, et al. (1990) Radical prostatectomy versus expectant primary treatment in stages I and II prostate cancer: a fifteen year follow-up. Urology 36: 493-498.
National Institute of Health (1987) Consensus Development Conference statement: the management of clinically localized prostate cancer. JAMA 258: 2727-2730.
Lu-Yao GL, Yao SL (1997) Population-based study of long-term survival in patients with clinically localised prostate cancer [see comments]. Lancet 349: 906-910.
del Regato JA, Trailins AH, Pittman DD (1993) Twenty years of follow-up of patients with inoperable cancer of the prostate (stage C) treated by radiotherapy: report of a national cooperative study. Int J Radiat Oncol Biol Phys 26: 197-201.
Babaian RJ, Zagars GK, Ayala AG (1990) Radiation therapy of stage C prostate cancer: significance of Gleason grade to survival. Semin Urol 8: 225-231.
Klabunde CN, Potosky AL, Harlan LC, Kramer BS (1998) Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care 36: 1337-1348.
Mettlin CJ, Murphy GP, Cunningham MP, Menck HR (1997) The National Cancer Data Base Report on Race, Age and Region Variations in Prostate Cancer treatment. Cancer 80: 1261-1266.
Imperato PJ, Nenner RP, Will TO (1996) Radical prostatectomy: lower rates among African-American men. J Natl Med Assoc 88: 589-594.
Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B (1995) Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 13: 93-100.
Schapira MM, McAuliffe TL, Nattinger AB (1995) Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care 33: 1079-1088.
Mettlin C, Murphy GP, Menck H (1994) Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Database, 1985–1990. Urology 43: 488-492.
Polednak AP, Flannery JT (1992) Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer 70: 2152-2158.
Desch CE, Penberthy L, Newschaffer CJ, et al. (1996) Factors that determine the treatment for local and regional prostate cancer. Med Care 34: 152-162.
Polednak AP (1998) Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc 90: 101-104.
Morris CR, Cohen R, Perkins CI, et al. (1999) Cancer in California, 1988–1996. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section.
Cancer Reporting in California (1995) Abstracting and Coding Procedures for Hospitals — California Cancer Reporting System Standards, Vol. 1. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section.
Shambaugh EM, WeissI MA (1977) Summary Staging Guide for the Cancer Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, MD: National Institutes of Health.
Stewart SL, Glaser SL, Horn-Ross PL, West DW (1993) SEER Study of Methods to Classify Hispanic Cancer Patients. Union City, CA: Northern California Cancer Center.
Krieger N (1992) Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82: 703-710.
Walter SD, Feinstein AR, Wells CK (1987) Coding ordinal independent variables in multiple regression analysis. Am J Epidemiol 125: 319-323.
Jones GW, Mettlin C, Murphy GP, et al. (1995) Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. J Am Coll Surg 180: 545-554.
Merrill RM (1996) Changes in the use of radical prostatectomy for treating prostate cancer in the United States. Lancet 348: 963-964.
Kaufman J, Cooper R, McGee D (1997) Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology 8: 621-628.
Optenberg SA, Thompson IM, Friedrichs P, et al. (1995) Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 274: 1599-1605.
Blendon RJ, Aiken LH, Freeman HE, Corey CR (1989) Access to medical care for black and white Americans. A matter of continuing concern. JAMA 261: 278-281.
Smith GE, DeHaven MJ, Grundig JP, Wilson GR (1997) African-American males and prostate cancer: assessing knowledge levels in the community. J Natl Med Assoc 6: 387-391.
Haynes MA, Smedley BD (1999) The Unequal Burden of Cancer: an Assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. Washington, DC: Institute of Medicine.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morris, C.R., Snipes, K.P., Schlag, R. et al. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Cancer Causes Control 10, 503–511 (1999). https://doi.org/10.1023/A:1008951009959
Issue Date:
DOI: https://doi.org/10.1023/A:1008951009959